CytoDyn (OTCQB:CYDY) is collaborating with the U.K.’s Department of Health to provide emergency access to leronlimab, an investigational medicine for COVID-19.
The submission to Medicines and Healthcare Products Regulatory Agency (MHRA) is expected soon to include clinical trial sites in the U.K.
U.K. representatives are coordinating with CytoDyn’s international clinical research organization, Amarex Clinical Research, to prepare the requisite clinical agreements and to prepare for timely delivery of leronlimab.
The FDA has cleared the Company to initiate a Phase 2b/3 clinical trial COVID-19 patients for which enrollment is now underway.
Per Johns Hopkins Case Tracker, global confirmed COVID-19 cases are now 1,407,123, up 7.5% from yesterday. Fatalities are up 11.2% to 80,759. Leaders:
U.S.: 383,256 (+10.4%)/12,021 (+17.6%).
Spain: 140,511 (+4.1%)/13,897 (+5.5%).
Italy: 135,586 (+2.2%)/17,127 (3.7%).
France: 110,043 (+17.3%)/10,343 (+15.9%).
Germany: 106,739 (+5.5%)/1,942 (+15.8%).
Cases and deaths appear to have finally peaked (al least preliminarily) both in New York and the U.S.
The declines are continuing in Italy and Spain while cases in France and the UK are ramping up. Germany appears to have peaked as well.
Aimed at easing short-term financial pressures caused by the COVID-19 pandemic, UnitedHealth Group (NYSE:UNH) is accelerating payments and other financial support to front-line healthcare providers.
It has also suspended prior authorization requirements to a post-acute care setting and when a member transfers to a new provider.
Other measures include extending timely filing deadlines for Medicare Advantage, Medicaid and Individual and Group Market health plans and implementing provisional credentialing to make it easier for out-of-network licensed clinicians to participate in UNH networks.
The state of New York says the number of new coronavirus cases declined for a third straight day to 8,147 on Tuesday vs. 8,658 on Monday.
The increase in ICU admissions related to coronavirus also decreased for the third day.
However, the number of coronavirus deaths rose by 731 yesterday, the single-business daily jump in virus deaths since the outbreak began, Governor Andrew Cuomo said.
At the White House coronavirus briefings, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has explained that the peak of death will generally lag the apex of hospitalizations.
New York City Mayor Bill de Blasio said the number of COVID-19 patients being placed on ventilators has been better than expected in recent days.
Gilead Sciences (NASDAQ:GILD) has finalized its $4.9B acquisition of Forty Seven (NASDAQ:FTSV) announced in early March.
FTSV’s lead candidate is magrolimab, a CD47-targeting monoclonal antibody in Phase 2 development for myelodysplastic syndromes and acute myeloid leukemia.
